SUMMARY 110 cases of optic neuritis were prospectively studied. 62 (56%) developed multiple sclerosis, 13 were lost to survey. However, eight of these had recurrent episodes of optic neuritis. If recurrent episodes of optic neuritis are accorded the same significance as demyelination elsewhere in the CNS, then the incidence of multiple sclerosis in the series rose to 71%, similar to that predicted on an actuarial basis.
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Optic nerve demyelination occurs at some stage in the course of multiple sclerosis in almost every patient.' However, the risk reported in the literature of patients with optic neuritis developing multiple sclerosis varies widely. Kurland et al2 placed the percentage at 11-5%, whereas Lynn3 and McAlpine4 found that 85% of optic neuritis cases developed multiple sclerosis. These studies were retrospective. In a prospective study of sixty-one cases Sandberg Wollheims found 27% of cases developed multiple sclerosis and Cohen et a16 followed sixty cases of optic neuritis and found 28% later developed multiple sclerosis. There is a wide variance in the series reported from the United States and those of European studies, and the possibility of some geographical basis arises.
Methods
Between 1953 and 1982 the author saw one-hundredand-ten cases of optic neuritis in three hospitals as a visiting neurologist, or in private practice-the majority being referred by ophthalmologists. The cases selected had no previous history or evidence of demyelination elsewhere in the central nervous system. There was no history of heavy alcohol intake, smoking, or a family history of visual failure. Examination revealed no evidence of retinal disease and no evidence of hypertension, (blood pressure 160/ 100 mmHg, or greater).
The clinical syndrome of optic neuritis was defined as a rapid loss of vision associated with a central or paracentral scotoma with a good prognosis for the recovery of vision. In the differential diagnosis of the condition, central serous retinopathy, neurosyphilis, toxic optic atrophy, ischaemic optic neuritis, optic nerve glioma and optic nerve compression had all been considered. While many of these cases were seen before the development of evoked visual responses, all were tested with the Ishiara charts to determine if the non-affected eye had any evidence of involvement. The cases were followed over a prolonged period to determine how many developed multiple sclerosis and if any identifiable factors could be determined. The sex, age of onset, the number of attacks of optic neuritis, and the interval to the development of multiple sclerosis were assessed, and more recently HLA antigen studies and evoked visual responses were performed. The follow-up was by letter and then interview, and where letters were returned unclaimed, a search of the State Electoral Rolls was made to see if the patient was still residing in the State.
Results
In 110 cases there were 68 females and 42 males, confirming the preponderance of females. The age of onset ranged between 10 and 50 years with the major group between 20 and 41 years. 106 cases developed clinical signs of optic neuritis or had a history of optic neuritis. In one case the episode of optic neuritis had occurred twenty-seven years before the next episode of demyelination. One of the patients with optic neuritis, who showed no evidence of demyelination elsewhere in the central nervous system, had a second episode in the contralateral eye twenty-five years after the first attack.
Conclusions
The nrsk of developing multiple sclerosis in patients suffering from optic neuritis in tropical and subtropical areas of Queensland and northern New South Wales is similar to that in temperate climates overseas. The majority of patients will develop multiple sclerosis. The signs of multiple sclerosis will usually become manifest in the first 2 years after the first attack of optic neuritis, and careful neurological examination of the patient should be conducted during this period.
If the significance of recurrent optic neuritis is the same as demyelination elsewhere in the central nervous system, then the incidenwce of multiple sclerosis in this series rose to 71 %, similar to that which could be projected on an actuarial basis. 
